Article

Competent immune responses to SARS-CoV-2 variants in older adults following mRNA vaccination

2021-07-22

Abstract excerpt

Aging is associated with a reduced magnitude of primary immune responses to vaccination and constriction of immune receptor repertoire diversity. Clinical trials demonstrated high efficacy of mRNA based SARS-CoV-2 vaccines in older adults but concerns about virus variant escape have not been well addressed. We have conducted an in-depth analysis of humoral and cellular immunity against an early-pandemic viral isol...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4ecf306e-1311-5b56-8eb7-7f7fa2d0cefb
DOI: 10.1101/2021.07.22.453287

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Competent immune responses to SARS-CoV-2 variants in older adults following mRNA vaccinationDOI 10.1101/2021.07.22.453287Read

Age-related heterogeneity in immune responses to SARS-CoV-2 vaccine BNT162b2Semantic proximity Read

Three doses of Sars-CoV-2 mRNA vaccine in older adults result in similar antibody responses but reduced cellular cytokine responses relative to younger adultsSemantic proximity Read

STUDY PROTOCOL A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): A trial conducted within the VACCELERATE networkSemantic proximity Read

Age-related heterogeneity in immune responses to SARS-CoV-2 following BNT162b2 vaccinationSemantic proximity Read

Determinants of early antibody responses to COVID-19 mRNA vaccines in exposed and naive healthcare workersSemantic proximity Read

Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variantsSemantic proximity Read

Longitudinal Analysis Reveals Distinct Antibody and Memory B Cell Responses in SARS-CoV2 Naïve and Recovered Individuals Following mRNA VaccinationSemantic proximity Read

Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variantsSemantic proximity Read

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older AdultsSemantic proximity Read

Atypical B cells and impaired SARS-CoV-2 neutralization following heterologous vaccination in the elderlySemantic proximity Read

BNT162b2 Vaccination in People Over 80 Years of Age Induces Strong Humoral Immune Responses with Cross Neutralisation of P.1 Brazilian VariantSemantic proximity Read

Reactogenicity, Safety, and Serological and Cellular Immunogenicity of a Booster Dose of SARS-CoV-2 mRNA Prototype, Variant, and Bivalent VaccinesSemantic proximity Read